Macrolide antibiotics and pulmonary inflammation

FEMS Microbiology Letters

Volumn 205, Issue 1, 2001, Pages 1-7

  Hoyt, Jeffrey C ^a   Robbins, Richard A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Asthma; Cytokine; Diffuse panbronchiolitis; Erythromycin; Inflammation; Interleukin 8; Macrolide

Indexed keywords

AZITHROMYCIN; CALCINEURIN; CLARITHROMYCIN; CYTOKINE; DIRITHROMYCIN; ERYTHROMYCIN DERIVATIVE; HMR 3004; INTERLEUKIN DERIVATIVE; JOSAMYCIN; MACROLIDE; METHACHOLINE; NITRIC OXIDE; RAPAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BACTERIAL INFECTION; BRONCHIOLITIS; CELL INFILTRATION; CHEMOTAXIS; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MACROPHAGE; NONHUMAN; PNEUMONIA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT DISEASE; SHORT SURVEY; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANTI-BACTERIAL AGENTS; ASTHMA; BRONCHIOLITIS; HUMANS; INFLAMMATION; LUNG; MACROLIDES;

EID: 0035960730     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(01)00443-8     Document Type: Short Survey

References (50)

1. The use of macrolide antibiotic substances in the treatment of asthma
2. Macrolides, asthma, inflammation, and infection
3. Potential role of macrolides in the treatment of asthma
4. Erythromycin and diffuse panbronchiolitis
5. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients
6. Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004
7. Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa
8. Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells
9. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice
10. Immunomodulation by macrolide antibiotics
11. Anti-inflammatory activity of macrolide antibiotics
12. Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages
13. Anti-inflammatory activity of macrolides: A new therapeutic potential?
14. Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
15. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
16. The anti-inflammatory effects of macrolides
17. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells
18. Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro
19. In vitro interaction between spiramycin and polymorphonuclear neutrophils oxidative metabolism
20. In vitro effects of spiramycin and dirithromycin on IL1 beta production by human LPS-stimulated mononuclear cells
21. Antiasthmatic activity of a macrolide antibiotic, roxithromycin: Analysis of possible mechanisms in vitro and in vivo
22. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma
23. Anti-inflammatory effects of macrolides in lung disease
24. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors
25. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
26. Characterization of the anti-inflammatory effect of FK-506 on human mast cells
27. Anti-inflammatory effect of FK 506 on human basophils
28. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells
29. FK506 attenuates developing and established joint inflammation and suppresses interleukin 6 and nitric oxide expression in bacterial cell wall induced polyarthritis
30. Inhibitory effect of FK 506 and cyclosporin A on nitric oxide production by LPS-treated cultured rat macrophages
31. The TOR kinases link nutrient sensing to cell growth
32. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma
33. Anti-T cell strategies in asthma
34. Effects of dirithromycin and erythromycylamine on human neutrophil degranulation
35. Biofilm disease: Its clinical manifestation and therapeutic possibilities of macrolides
36. Macrolide antibiotics protect against immune complex-induced lung injury in rats: Role of nitric oxide from alveolar macrophages
37. Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro
38. Erythromycin suppresses interleukin 6 expression by human bronchial epithelial cells: A potential mechanism of its anti-inflammatory action
39. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro
40. Effects of long-term administration of erythromycin on cytokine production in rat alveolar macrophages
41. Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils
42. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway: L-cladinose is involved both in alterations of neutrophil functions and modulation of this transductional pathway
43. Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae
44. Correlation between secretion and phospholipase D activation in differentiated HL60 cells
45. Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells
46. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells
47. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells